Sort
16,300 grants matching “fatty liver disease”
Atheroregression via Enhanced Reverse Cholesterol Transport
$586,323Henry J. Pownall · Methodist Hospital Research Institute · R01 · FY2015 · HL
Microbial Disruption of Dendritic Cell Maturation and Function
$586,138Caroline A Genco · Tufts University Boston · R01 · FY2022 · AI
A PSGL-1 Glycopeptide Mimetic for Treatment of Metabolic Syndrome
$586,112Elliot Chaikof · Beth Israel Deaconess Medical Center · R01 · FY2019 · DK
Project2: Impact of adipose-tissue derived FGF21 on immunometabolic control of aging
$586,077Philipp E Scherer · Yale University · P01 · FY2022 · AG
Advancing 3D optical body surface scan technology to assess physiological and psychological effects in highly obese population
$586,009James K Hahn · George Washington University · R01 · FY2022 · DK
Intestinal Resection Associated Liver Injury and Fibrosis
$585,979Brad Wayne Warner · Washington University · R01 · FY2022 · DK
Adipose Tissue Macrophage Phenotype and Function
$585,977Anthony W Ferrante · Columbia University Health Sciences · R01 · FY2025 · DK
Overcoming FVIII protein misfolding and cell toxicity
$585,948Randal J. Kaufman · Indiana University Indianapolis · P01 · FY2022 · HL
Liver Cancer Risk with rAAV Gene Therapy
$585,925Markus Grompe · Oregon Health & Science University · R01 · FY2017 · CA
Systems genetics approaches to bile acid metabolisms
$585,905Karen Reue · University Of California Los Angeles · P01 · FY2016 · HL
New Approaches to the Evaluation and Treatment of Acromegaly
$585,608Pamela U Freda · Columbia University Health Sciences · R01 · FY2017 · DK
New Approaches to the Evaluation and Treatment of Acromegaly
$585,608Pamela U Freda · Columbia University Health Sciences · R01 · FY2020 · DK
New Approaches to the Evaluation and Treatment of Acromegaly
$585,608Pamela U Freda · Columbia University Health Sciences · R01 · FY2019 · DK
PQB-3: Discovery and validation of the driving mediators of cancer cachexia
$585,575Todd R. Golub · Broad Institute, Inc. · R01 · FY2017 · CA
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
$585,501Arun J Sanyal · Virginia Commonwealth University · U01 · FY2014 · DK
Prevention of Pediatric NAFLD in Hispanic Children
$585,432Miriam B. Vos · Emory University · R01 · FY2022 · NR
Mapping Diabetes Susceptibility by Expression Traits in African Americans
$585,302Swapan Kumar Das · Wake Forest University Health Sciences · R01 · FY2014 · DK
CVD in American Indians Genetics Center
$585,278Shelley A Cole · Texas Biomedical Research Institute · R01 · FY2014 · HL
Integrative Physiology of Thyroid Hormone Receptors and Nuclear Receptor Corepressors
$585,267Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2024 · DK
Integrative Physiology of Thyroid Hormone Receptors and Nuclear Receptor Corepressors
$585,267Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2025 · DK
Improving Liver Ultrasound Image Quality in Difficult-to-Image Patients
$585,234Jeremy Dahl · Stanford University · R01 · FY2021 · EB
Advancing MRI with an open inhomogeneous B0 magnet
$585,213R. Todd Constable · Yale University · R01 · FY2025 · EB
Homeostatic Role of IRE1a-XBP1-PDI1 in Hepatic Lipid Metabolism
$585,000Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · DK
Homeostatic role of IRE1a-XBP1-PDI1 in hepatic lipid metabolism
$585,000Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · DK
Homeostatic role of IRE1a-XBP1-PDI1 in hepatic lipid metabolism
$585,000Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · DK